79
70
Growth Score
-9 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1751301
Genetics Institute is a U.S.-based biotechnology research and development company.
Ted Yednock: Team MemberPast Role: Neotope Biosciences Limited, CEO
Raju Kucherlapati: Paul C. Cabot ProfessorPast Role: Metamark Genetics, Founding Advisor, Chair of the Scientific Advisory Committee
About the Company
Genetics Institute is a U.S. based biotechnology research and development company.
The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells.
The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of
Ptashne’s home.
Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.
